COMPANY PROFILE / #3085
Hypervision Surgical
London, United KingdomVenture Capital-Backed
OVERVIEW
Developer of an imaging system designed to equip clinicians with advanced computer-assisted tissue analysis for surgical precision and patient safety. The company's non-contact and non-invasive optical imaging system splits light into multiple spectral bands, offering AI-based, wide-field, real-time, data-driven tissue characterization, enabling surgeons to visualize and characterize tissue intraoperatively without injecting any contrast agents and minimizing patient risk.
已融资31.61
最新估值48.49
员工数28
成立年份2020
公司概况
- Companies
- Hypervision Surgical
- Description
- Developer of an imaging system designed to equip clinicians with advanced computer-assisted tissue analysis for surgical precision and patient safety. The company's non-contact and non-invasive optical imaging system splits light into multiple spectral bands, offering AI-based, wide-field, real-time, data-driven tissue characterization, enabling surgeons to visualize and characterize tissue intraoperatively without injecting any contrast agents and minimizing patient risk.
- Website
- www.hypervisionsurgical.com
- HQ Location
- London, United Kingdom
- Year Founded
- 2020
- Keywords
- artificial intelligence, medical imaging, optical imaging system, surgical imaging and navigation, surgical test, tissue characterisation system, tissue diagnostics, tissue imaging technology
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 31.61
- First Financing Date
- 01-Jan-2020
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 29-Apr-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 22.81
- Last Financing Valuation
- 48.49
- Last Financing Status
- Completed
- Last Known Valuation
- 48.49
- Last Known Valuation Date
- 29-Apr-2026
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 60.87
- Valuation Estimate Growth Rate
- 25.53%
- Active Investors
- Angelini Ventures, Creative Destruction Lab, Enterprise Hub - Royal Academy of Engineering, Heal Capital, HERAN Partners, Innovate UK, IP Group, King's College London, Life Extension Ventures, LifeX Ventures, MedTech Innovator, Meridian Health Ventures, NIHCM Foundation, Redalpine, SAGES Ingenuity, Sonorcap, TAcc+, ZEISS Ventures
- # Active Investors
- 18
- Acquirers
- —
团队与联系人
- Employees
- 28
- Employee Growth %
- 33.33%
- Employee History
- 2026: 28, 2025: 21, 2024: 20, 2023: 17, 2022: 6, 2021: 6
- Primary Contact
- Michael Ebner
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- michael.ebner@hypervisionsurgical.com
- Primary Contact Phone
- +44 (0)74 8049 9711
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.47%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 94
- Size Multiple
- 3.09x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 75
- Majestic Referring Domains
- 99
- SimilarWeb Unique Visitors
- 201
- SimilarWeb Unique Visitors Change
- -56
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 3%
- Success Probability Over Time – 3 Year
- 10%
- Success Probability Over Time – 5 Year
- 27%
记录来源：public.companies · 原始序号 #3085 · 所有字段均按数据库原值展示。